Security Snapshot

Peoples Bank of Commerce Orego - COM (PBCO) Institutional Ownership

CUSIP: 710311101

13F Institutional Holders and Ownership History from Q2 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

1

Shares (Excl. Options)

98,057

Price

$17.95

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Type / Class
Equity / COM
Symbol
PBCO
Price per share
$18.39
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
98,057
Total reported value
$1,760,123
Share change
0
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • PBCO - Peoples Bank of Commerce Orego - COM is tracked under CUSIP 710311101.
  • 1 institution reported positions in Q4 2025.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 1 to 1 between Q4 2025 and Q1 2026.
  • Reported value moved from $1,760,123 to $1,803,268.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 1 institution filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 710311101?
CUSIP 710311101 identifies PBCO - Peoples Bank of Commerce Orego - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 1 institutional investors reported holding 98,057 shares of Peoples Bank of Commerce Orego - COM (PBCO).

Institutional Holders of Peoples Bank of Commerce Orego - COM (PBCO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 98,057 $1,803,268 $18.39 1
2025 Q4 98,057 $1,760,123 $17.95 1
2025 Q3 98,057 $1,618,921 $16.51 1
2025 Q2 98,057 $1,420,846 $14.49 1
2025 Q1 98,057 $1,416,924 $14.45 1
2024 Q4 98,057 $1,397,312 $14.25 1
2024 Q3 98,057 $1,354,167 $13.81 1
2024 Q2 98,057 $1,174,723 $11.98 1
2024 Q1 98,057 $1,152,170 $11.75 1
2023 Q4 98,057 $1,323,769 $13.50 1
2023 Q3 98,057 $1,127,655 $11.50 1
2023 Q2 98,057 $1,083,530 $11.05 1
2023 Q1 98,057 $1,225,712 $12.50 1
2022 Q4 98,057 $1,329,000 +$63,267 $13.55 1
2022 Q3 93,389 $1,349,000 $14.44 1
2022 Q2 93,389 $1,335,000 $14.30 1
2022 Q1 93,389 $1,639,000 $17.55 1
2021 Q4 93,389 $1,685,000 $18.04 1
2021 Q3 93,389 $1,420,000 +$67,618 $15.21 1
2021 Q2 88,942 $1,460,000 $16.42 1
2021 Q1 88,942 $1,294,000 +$5,529 $14.55 1
2020 Q4 88,562 $1,163,000 -$93,000 $13.13 1
2020 Q3 97,410 $1,027,000 -$187,093 $10.53 2
2020 Q2 115,210 $1,323,000 -$927,259 $11.67 2
2020 Q1 193,110 $2,033,000 -$342,066 $10.53 2
2019 Q4 225,152 $3,265,000 -$145,036 $14.50 2
2019 Q3 235,152 $3,500,000 -$328,241 $14.89 2
2019 Q2 257,252 $3,645,000 +$1,426,943 $14.38 2
2019 Q1 165,420 $2,523,000 -$15,252 $15.25 1
2018 Q4 166,420 $2,165,000 -$151,896 $13.01 1
2018 Q3 178,096 $2,476,000 +$60,768 $13.90 1
2018 Q2 173,725 $2,338,000 -$90,546 $13.46 1
2018 Q1 180,453 $2,454,000 +$43,028 $13.60 1
2017 Q4 177,289 $2,287,028 $12.90 1
2017 Q3 177,289 $2,232,000 -$238,460 $12.59 1
2017 Q2 196,230 $2,453,000 +$116,793 $12.50 1
2017 Q1 186,887 $2,196,000 $11.75 1
2016 Q4 186,887 $1,897,000 $10.15 1
2016 Q3 186,887 $1,744,000 -$9 $9.33 1
2016 Q2 186,888 $1,751,000 +$83,377 $9.37 1
2016 Q1 177,989 $1,301,000 +$25,700 $7.31 1
2015 Q4 174,473 $1,684,000 $9.65 1
2015 Q3 174,473 $1,657,000 +$165,184 $9.50 1
2015 Q2 157,080 $1,414,000 $9.00 1
2015 Q1 157,080 $1,484,000 +$70,667 $9.45 1
2014 Q4 149,600 $1,460,000 +$46,845 $9.76 1
2014 Q3 144,800 $1,361,000 +$18,798 $9.40 1
2014 Q2 142,800 $1,385,000 +$1,385,000 $9.70 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .